MedTrace Logo

Deciphering the Role of Oxytocin in Motivation: an fMRI Study

NCT01722071 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-01-29

Study results available
· View outcomes & findings →

Summary

The proposed study will investigate the effects of intranasal oxytocin administration on neural activity associated with social and non-social motivation.

Conditions

  • Focus of Study: Neural Correlates of Oxytocin Administration

Interventions

DRUG

Placebo

Placebo intranasal administration, 3 puffs per nostril delivered approximately 30 minutes prior to scanning session.

DRUG

Oxytocin

Oxytocin intranasal administration, 24 IU, 3 puffs per nostril at 4 IU per puff delivered approximately 30 minutes prior to scanning session.

Sponsors & Collaborators

Principal Investigators

  • Tiffany M Love, PhD · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-09-30
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01722071 on ClinicalTrials.gov